Overall rank by patents
#46,009
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView US Corporation
Cytosaver Llc
USPTO PatentsView assignee record - 5 granted patents across 5 technology areas, active 2015–2022. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: B01L (CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE).
5
Total patents granted
5
CPC technology areas
18.0
Avg claims per patent
-75%
5-year filing velocity
The verdict
Cytosaver holds 5 US patents across 5 technology areas, rank #46,009 of 50,000 tracked assignees.
- #46,009
- of 50,000 US assignees by volume
- Top 62%
- by Innovation Score (31.6/100)
- 18.0
- avg claims per patent
- -75%
- filing velocity, last 5 yrs
Portfolio overview
Cytosaver Llc has been granted 5 US utility patents between 2015 and 2022, placing Cytosaver Llc at rank #46,009 across all assignees tracked by PlainPatent. This portfolio spans 5 distinct Cooperative Patent Classification (CPC) subclasses, averaging 18.0 claims per patent with primary concentration in B01L (CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE). As a US Corporation, Cytosaver Llc is one of the more focused assignees in the PatentsView dataset. By volume, Cytosaver sits between Cyberpoint International Llc (5 patents, rank #46,005) and D And M Asset Management, Llc (5 patents, rank #46,013) - the closest US assignees by grant volume. The composite Innovation Score of 31.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 1 grants, compared with 4 in the 2015–2019 window, a -75% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Cytosaver Llc's 18.0 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 5 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Cytosaver Llc against peers pursuing similar technology classes.
Who files at Cytosaver's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Cyberpoint Intern…
Cyberpoint International LLC
5 patents
- Cyclopure
CycloPure, Inc.
5 patents
- Cyclone Filter To…
Cyclone Filter Tools LLC
5 patents
- Cytex Therapeutics
Cytex Therapeutics, Inc.
5 patents
- Cyxtera Cybersecu…
Cyxtera Cybersecurity, Inc.
5 patents
- Cyxtera Data Cent…
Cyxtera Data Centers, Inc.
5 patents
- D Morrison Consul…
D Morrison Consulting Inc.
5 patents
- D and M Asset Man…
D and M Asset Management, LLC
5 patents
- Cytosaver ◀
CytoSaver LLC
5 patents
What this shows Cytosaver holds 5 patents at rank #46,009, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Cytosaver
By rank, the assignees closest to #46,009 in granted patent volume.
- Cyberpoint International Llc #46,005 · 5 patents
- Cyclopure, Inc. #46,006 · 5 patents
- Cyclone Filter Tools Llc #46,007 · 5 patents
- Cytex Therapeutics, Inc. #46,008 · 5 patents
- Cyxtera Cybersecurity, Inc. #46,010 · 5 patents
- Cyxtera Data Centers, Inc. #46,011 · 5 patents
- D Morrison Consulting Inc. #46,012 · 5 patents
- D And M Asset Management, Llc #46,013 · 5 patents
Leaders in B01L (Chemical OR Physical Laboratory Apparatus FOR General USE)
Other assignees with the most granted patents in Cytosaver's primary technology class.
- The Regents Of The University Of California 239 in class
- Illumina, Inc. 232 in class
- Becton, Dickinson And Company 193 in class
- Bio-rad Laboratories, Inc. 174 in class
- President And Fellows Of Harvard College 165 in class
- Life Technologies Corporation 158 in class
- Roche Diagnostics Operations, Inc. 141 in class
- Siemens Healthcare Diagnostics Inc. 119 in class
Cytosaver's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
32 Top 62% higher than 38% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 20.0% |
| 2016 | 2 | 40.0% |
| 2018 | 1 | 20.0% |
| 2022 | 1 | 20.0% |
Which technologies does Cytosaver Llc patent most?
Top 5 of 5 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Focused
Claim Depth Standard
Velocity Declining
Frequently Asked Questions
How many patents does Cytosaver Llc hold?
Cytosaver Llc holds 5 US granted patents filed between 2015 and 2022, spanning 5 technology areas.
What is Cytosaver Llc's Innovation Score?
Cytosaver Llc has an Innovation Score of 31.6 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Cytosaver Llc focus on?
Cytosaver Llc's top technology area is B01L (CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE) with 4 patents. The company has filed patents in 5 CPC subclasses total.
Is Cytosaver Llc's patent filing rate increasing or decreasing?
Cytosaver Llc's recent filing velocity is -75% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for Cytosaver Llc's patents?
Cytosaver Llc's patents average 18.0 claims each. This falls within the standard range, providing solid legal coverage.
How is the Cytosaver Llc patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
Cytosaver's 5 grants land it in the top 62% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - Cytosaver ranks #46,009 of 50,000. Top 50 holders
- Most of this portfolio concentrates in B01L - see who else leads that technology area. B01L leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.